Chemotherapy Induced Anemia Market Forecast and Segments, 2016-2026

pradnya.86

Chemotherapy induced anemia market are witnessing maximum growth owing to increase in the prevalence of cancer and anemia among geriatric patients, bone marrow invasion, increase in pipeline products, advancement in the technology, reimbursement policy and increase in chronic inflammatory conditions.

Chemotherapy

Induced Anemia

Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

20162026

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com


Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We

combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our

client.

Research

Sector Coverage

Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

• Automotive and Transportation

• Chemicals & Materials

• Electronics, Semiconductor, and ICT • Food and Beverages

• Retail and Consumer Products

• Services and Utilities

• Industrial Automation and Equipment • Energy, Mining, Oil, and

• Healthcare, Pharmaceuticals & Medical Devices Gas

Customized

Research

Syndicated

Research

Investment

Research

Social Media

Research

Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com


Report Description

Anemia is a most common hematologic disorder in majority of cancer patients receiving

chemotherapy treatment. Anemia is a condition in which person do not have sufficient red

blood cells in the body or low ability of hemoglobin to carry oxygen and circulate it to all cells in

the body. Anemia can be caused by cancer treatment, low iron levels in body, organ problems,

chronic kidney disease and thalassemia. Moreover, some other risk factors that can develop

anemia among cancer patients are namely platinum based chemotherapy, low level of red blood

cells before having cancer and certain tumor type. To find out the cause of anemia certain tests

need to be done such as blood chemistry tests, reticulocyte count, stool test and bone marrow

exam. In Europe, the study has been conducted by European Cancer Anemia Survey (ECAS)

across 24 nations stated that around 83% of the patients going for chemotherapy demonstrated

anemia disorder. Anemia often exhibit symptoms such as fatigue, dyspnea, chest pain and fast

heartbeat. It has been estimated that about 50% of the cancer patients suffering from anemia

did not received any treatment. However, patients with head and neck cancer suffering from

anemia have risk of death is around 19% and 47% with prostate cancer patients.

Chemotherapy Induced Anemia Market:Drivers and Restraints

Chemotherapy induced anemia market are witnessing maximum growth owing to increase in

the prevalence of cancer and anemia among geriatric patients, bone marrow invasion, increase

in pipeline products, advancement in the technology, reimbursement policy and increase in

chronic inflammatory conditions..


Report Description

Moreover, side effects of the cancer treatment can develop anemia and increase in various

etiologies of anemia in cancer patients are some other factors expected to flourish the

chemotherapy induced anemia market. However, side effects of drugs, increase in the mortality

rate and risk associated with treatment may hamper the growth of chemotherapy induced

anemia market in near future.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-

1757

Chemotherapy Induced Anemia Market:Segmentation

The chemotherapy induced anemia market has been classified on the basis of range of anemia,

treatment type, drug type and end user.

‣ Based on rang of anemia, the chemotherapy induced anemia market is segmented into the

following:

• Mild Anemia

• Moderate Anemia

• Severe Anemia

• Life-threatening Anemia


Report Description

‣ Based on treatment type, the chemotherapy induced anemia market is segmented into the

following:

• RBC Transfusions

• Erythropoiesis-stimulating agents (ESAs)

• Iron Supplementation

‣ Based on drug type, the chemotherapy induced anemia market is segmented into the

following:

• Epogen Injection

• Procrit Injection

• Androxy Oral

• Aranesp injection

• Epoetin Alfa Injection

• Other

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1757

‣ Based on end-user, the chemotherapy induced anemia market is segmented into the

following:

• Hospitals

• Ambulatory Surgical Centers


Report Description

• Multispecialty Clinics

• Cancer Research Centers

• Cancer Rehabilitation Centers

Chemotherapy Induced Anemia Market:Overview

In Japan, cancer patients with anemia disorder are treated with RBC transfusions. On the other

hand, in USA and Europe patients with chemotherapy induced anemia are treated with

erythropoiesis stimulating agents namely epoetin & darbepoetin. Fatigue is the most severe

symptoms of chemotherapy induced anemia among cancer patients and experience fatigue in

moderate to severe range of anemia. Patients received platinum, gemcitabine and anthracycline

based regimens has high chances of develop anemia.

Chemotherapy Induced Anemia Market: Region-wise Outlook

Depending on geographic region, Chemotherapy Induced Anemia Market is segmented into

seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific,

Japan, and Middle East & Africa. Asia Pacific dominates the chemotherapy induced anemia

marketfollowed by Europe, Japan and North America owing to high awareness of disease among

population, government initiatives, great advancement in the field of chemotherapy induced

anemia and developed healthcare infrastructure in these regions.


Report Description

Asia Pacific, Middle East and Africa hold huge potential and shows substantial growth in terms of

wide acceptance of new technologyowing to high mortality rate, prevalence of anemia among

cancer patients, increasing healthcare expenditure and high potential customer base need

treatment for chemotherapy induced anemia.

Chemotherapy Induced Anemia Market:Key Players

Key players of Chemotherapy Induced Anemia Marketare Dr. Reddy’s Laboratories Ltd., Pfizer

Inc., SBI Pharmaceuticals Co., Ltd, Panacea Biotec Limited, Panacea Biotec., 3SBio Inc., Tolero

Pharmaceuticals, Inc., Vifor Pharma AG and Therapure Biopharma Inc.


Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

sales@futuremarketinsights.com

For other queries contact:

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines